Skip to content
MedsAcross

Brand family

Simponi

Golimumab · Janssen Biotech
United States
Presentations
2
Markets
1

Simponi is a brand of Golimumab marketed by Janssen Biotech, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Golimumab
Brand owner
Janssen Biotech
Registered in
United States
Strengths and forms
100 mg/1 mL injection, 50 mg/0.5 mL injection

All presentations

MedicineManufacturerRegisterAvailability
Simponi 100 mg/1 mL injectionSubcutaneous Cold chainJanssen BiotechUS FDAAvailable on request
Simponi 50 mg/0.5 mL injectionSubcutaneous Cold chainJanssen BiotechUS FDAAvailable on request

Equivalent brands

Other brands of Golimumab.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Simponi

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.